DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

We're going to check out a few of the best picks from our screener tool. Overview: Bitdeer Technologies Group is a technology company focused on blockchain and computing, with a market cap of $1.67 ...

Dominic Walsh, a business reporter who previously covered the leisure and drinks industry for The Times from 1997 to 2024, stated in post to X: ...

Mamtani covers the Healthcare sector, focusing on stocks such as Cytokinetics, Novavax, and TG Therapeutics. According to TipRanks, Mamtani has an average return of -10.8% and a 28.60% success rate on ...

VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q2 2025 Earnings Call Transcript November 10, 2024 Operator: Good afternoon, ladies and gentlemen, and welcome to the Vistagen Therapeutics Fiscal Year 2025 ...

As global markets experience a rally driven by expectations of growth and tax reforms following recent U.S. elections, small-cap stocks like those in the Russell 2000 Index have shown significant ...

TG Therapeutics (NASDAQ:TGTX – Free Report) had its target price increased by HC Wainwright from $49.00 to $55.00 in a report ...

On Friday, TG Therapeutics Inc common stock (TGTX) stock saw a modest uptick, ending the day at $28.81 which represents a slight increase of $0.91 or 3.26% from the prior close of $27.9. The stock ...

Over the last 7 days, the United States market has risen by 5.1%, contributing to an impressive 38% increase over the past year, with earnings forecasted to grow by 15% annually. In this context of ...

It's been a good week for TG Therapeutics, Inc. ( NASDAQ:TGTX ) shareholders, because the company has just released ...

Esperion Therapeutics (ESPR) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.37 per share a year ago. These ...

Third quarter 2024 U.S. BRIUMVI net revenue of $83.3 million Raises full year 2024 U.S. BRIUMVI net revenue target to $300 - $305 million Conference call to be held today, November 4, 2024, at 8:30 AM ...